Mevacor lovastatin regulatory update

FDA's Nonprescription Drugs Advisory Committee (NDAC) and the Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC) will meet on Dec. 13 to review an NDA from MRK for once-daily OTC Mevacor 20...